Ideal Time of Oxytocin Infusion During Cesarean Section

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Blood Loss, Surgical, Postpartum Hemorrhage, Bleed Pregnancy, Pregnancy Related, Cesarean Section Complications

In brief

This study will evaluate if the timing of oxytocin administration in cesarean deliveries will affect the amount of maternal blood loss. Half of participants will receive oxytocin after delivery of the fetal anterior shoulder and the other half will receive oxytocin after delivery of the placenta. We hypothesize that administering oxytocin after delivery of the shoulder, will result in less overall maternal blood loss.

Key facts

Study ID

NCT03246919

Run by

Loyola University

People needed

68

Starts

2017-09-13

Expected to finish

2020-02-24

Last updated by the study team

2020-06-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women undergoing cesarean section at Loyola Hospital
• Women who read and speak the English and/or Spanish language
• Women age 18 or older

You may not qualify if…

• Women who deliver vaginally
• Gestation under 37 weeks and 0 days
• Women with coagulopathies
• Multiple gestation pregnancies
• Antepartum hemorrhage for example abruption
• Placental abnormalities for example previa, accreta

Where it is running

• Loyola University Medical Center — Maywood, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.